Active

Contract Opportunity

This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America’s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)’s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.

The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:

(1) automated hematology analyzer, one (1) instrument starter pack: for animal blood that evaluates and provides the results of 27 parameters for each blood sample in approximately two minutes for veterinary use only. Will employ three state-of-the-art technologies—laser flow cytometry, optical fluorescence, and Laminar Flow Impedance—as well as the SLS-hemoglobin method with the following requirements/specifications:

Laser flow cytometry delivers an advanced five-part white blood cell differential.

Optical fluorescence provides a highly sensitive and accurate reticulocyte count.

Laminar Flow Impedence performs the fastest, most precise red blood cell count.

• The broadest hematology test menu in the veterinary industry


• Veterinary-specific algorithms for 17 species


• Load-and-go operation and results in just 2 minutes

• Detection of band neutrophils


• Reticulocyte count

• Reticulocyte hemoglobin (RETIC-HGB)


• True five-part white blood cell differential

• Detection of nucleated red blood cells


• The ability to run abdominal/thoracic, synovial fluid analyses

27 whole blood parameters plus fluid analysis.

Red blood cell parameters

• Red blood cell (RBC) count


• Hematocrit (HCT)


• Hemoglobin (HGB)


• Mean cell volume (MCV)


• Mean corpuscular hemoglobin (MCH)


• Mean corpuscular hemoglobin concentration (MCHC)


• Red blood cell distribution width (RDW)


• Reticulocytes (RETIC; % and #)


• Reticulocyte hemoglobin (RETIC-HGB)


• Nucleated red blood cells (nRBC; when presence suspected)

White blood cell parameters

• White blood cell (WBC) count


• Neutrophils (NEU; % and #)


• Lymphocytes (LYM; % and #)


• Monocytes (MONO; % and #)


• Eosinophils (EOS; % and #)


• Basophils (BASO; % and #)


• Band neutrophils (BAND; when presence suspected)

Platelet parameters

• Platelet (PLT) count


• Platelet distribution width (PDW)


• Mean platelet volume (MPV)


• Plateletcrit (PCT)

Fluid analysis parameters

• Total nucleated cell count (TNCC)


• Agranulocytes (AGRANS; % and #)


• Granulocytes (GRANS; % and #)


• Red blood cell (RBC) count

Dimensions & weight

• Width: 12.6 in (32 cm)


• Depth: 16.26 in (41.3 cm)


• Height: 15.8 in (40.3 cm)


• Weight: approximately 55 lb (25 kg)

Capability Statement/Information Sought

All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by April 26, 2024, by 11:00 AM EST.

Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.

Submission Instructions

Interested businesses who consider themselves qualified to provide an equal product that is manufactured in the United States for the above-listed product are invited to submit a response to this Sources Sought Notice by April 26, 2024, by 11:00 AM EST. All responses under this Sources Sought Notice must be emailed to directly to, Rita Davis: rita.davis@nih.gov with the Sources Sought ID# SS-NIAID-24-2216290 in email the subject line.

Disclaimer and Important Notes

This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality

No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

Attachments/Links